We have recently demonstrated for non-small cell lung carcinoma (NSCLC) cell lines, that EGFR inhibition by the small molecule inhibitor erlotinib induces a cell cycle arrest in G1. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.